Prevalence and ERG11-mediated itraconazole resistance in urinary Candida isolates: a cross-sectional study from a tertiary-care hospital

Background: This cross-sectional study characterized urinary Candida isolates and evaluated in-vitro itraconazole susceptibility using phenotypic and genotypic methods in a tertiary-care hospital. Methods: A total of 105 nonduplicate Candida isolates recovered from urine samples submitted for suspected UTI were identified by Gram staining, germ tube test, CHROMagar Candida , and sugar fermentation tests. Antifungal susceptibility to itraconazole and other azoles was assessed by Kirby–Bauer disk diffusion, and minimum inhibitory concentrations (MICs) were determined by microbroth dilution in accordance with CLSI guidelines. Real-time PCR targeting the ERG11 gene was performed to detect mutations associated with azole resistance. Results: Candida albicans was the most prevalent species (39%), followed by C. krusei, C. tropicalis, C. parapsilosis and C. glabrata . Itraconazole resistance was observed in 45.7% of isolates, with nonalbicans species contributing substantially to the resistant fraction. ERG11 mutations were detected in 40 itraconazole-resistant strains, showing strong correlation with phenotypic resistance profiles. Conclusion: The observed in-vitro itraconazole nonsusceptibility describes the sampled urinary isolates and does not establish itraconazole as a treatment option for Candida UTI or confirm infection in every culture-positive patient. These findings support diagnostic stewardship and more appropriate antifungal therapy in hospital and high-risk settings.

Authors

Publication Details

Journal
Reviews in Medical Microbiology
Published
2026-11-20
DOI
https://doi.org/10.1097/mrm.0000000000000486
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prevalence and ERG11-mediated itraconazole resistance in urinary Candida isolates: a cross-sectional study from a tertiary-care hospital

S.S. Jaya Lakshmi, Hanna Fathima, Leela Kakithakara Vajravelu, Anusha Gopinathan et al.
Reviews in Medical Microbiology
Antifungal resistance and susceptibility
article

Prevalence and ERG11-mediated itraconazole resistance in urinary Candida isolates: a cross-sectional study from a tertiary-care hospital

S.S. Jaya Lakshmi, Hanna Fathima, Leela Kakithakara Vajravelu, Anusha Gopinathan, Maheswary Datchanamoorthy
article en

Abstract

Background: This cross-sectional study characterized urinary Candida isolates and evaluated in-vitro itraconazole susceptibility using phenotypic and genotypic methods in a tertiary-care hospital. Methods: A total of 105 nonduplicate Candida isolates recovered from urine samples submitted for suspected UTI were identified by Gram staining, germ tube test, CHROMagar Candida , and sugar fermentation tests. Antifungal susceptibility to itraconazole and other azoles was assessed by Kirby–Bauer disk diffusion, and minimum inhibitory concentrations (MICs) were determined by microbroth dilution in accordance with CLSI guidelines. Real-time PCR targeting the ERG11 gene was performed to detect mutations associated with azole resistance. Results: Candida albicans was the most prevalent species (39%), followed by C. krusei, C. tropicalis, C. parapsilosis and C. glabrata . Itraconazole resistance was observed in 45.7% of isolates, with nonalbicans species contributing substantially to the resistant fraction. ERG11 mutations were detected in 40 itraconazole-resistant strains, showing strong correlation with phenotypic resistance profiles. Conclusion: The observed in-vitro itraconazole nonsusceptibility describes the sampled urinary isolates and does not establish itraconazole as a treatment option for Candida UTI or confirm infection in every culture-positive patient. These findings support diagnostic stewardship and more appropriate antifungal therapy in hospital and high-risk settings.

Reviews in Medical Microbiology
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon